Optical Genome Mapping (OGM) & Its Applications
A Series of Talks by Sciencewerke and Bionano – 25 & 26 September 2023
Join us for a series of talks on Optical Genome Mapping (OGM) and Its Applications, brought to you by Sciencewerke and Bianano on 25 & 26 September 2023!
Dr. Alka Chaubey, Chief Medical Officer of Bionano Genomics, Inc. will discuss global users and their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines.
What's more, register and attend the talk to receive a FREE goodie bag!
Refreshments will be served after the talk.
You may choose ONE of the dates & venue below:
a) 25 Sep 2023, Monday, 11am – 12noon: SGH Academia, Conference Room AC-7-1 (Level 7)
Topic: Modernize your cytogenetics workflow with Optical Genome Mapping
OGM allows scientists and clinical researchers the ability to discover genome-wide structural variations (SVs) in a way unmatched by traditional cytogenetic techniques. In this seminar, Dr. Alka Chaubey will discuss global users and their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines.
Click here to register!
b) 25 Sep 2023, Monday, 2pm – 3pm: NCCS, Meeting Room 18-1, Level 18
Topic: Optical Genome Mapping for Next-Generation Cytogenomics
OGM allows scientists the ability to discover chromosomal aberrations or structural variations (SVs), a hallmark of cancer, in a way unmatched by traditional cytogenetic techniques. In this seminar, Dr. Alka Chaubey will discuss global users and their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines.
Click here to register!
c) 26 Sep 2023, Tuesday, 10.30am – 11.30am: KKH Conference Room 1 (Women's Tower, Level 1, Training Centre, Retail Mall)
Topic: Modernize your cytogenetics workflow with Optical Genome Mapping
OGM allows scientists and clinical researchers the ability to discover genome-wide structural variations (SVs) in a way unmatched by traditional cytogenetic techniques. In this seminar, Dr. Alka Chaubey will discuss global users and their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines.
Click here to register!
d) 26 Sep 2023, Tuesday, 2pm – 3pm: NUS, MD6 Smart Classroom, Level 4
Topic: Optical Genome Mapping for Next-Generation Cytogenomics
OGM allows scientists the ability to discover chromosomal aberrations or structural variations (SVs), a hallmark of cancer, in a way unmatched by traditional cytogenetic techniques. In this seminar, Dr. Alka Chaubey will discuss global users and their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines.
Click here to register!
SPEAKER
Alka Chaubey, PhD, FACMG
Chief Medical Officer, Bianano Genomics, Inc.
Alka Chaubey is double board-certified in clinical cytogenetics/genomics and clinical molecular genetics/genomics by the American Board of Medical Genetics and Genomics (ABMGG).
Previously, she was the Head of Cytogenomics at PerkinElmer Genomics, where Dr. Chaubey led the successful development and launch of several innovative products including the CNGnome test (low-pass whole genome sequencing), and a new FSHD assay utilizing Saphyr. She has also played an integral role on Vanadis team at PerkinElmer in their efforts to bring a new PCR-free NIPT technology to the market. Prior to PerkinElmer Genomics, Dr. Chaubey was the Director of the Cytogenomics Laboratory at the Greenwood Genetic Center, SC, USA. She also holds an academic appointment as the Scientific Director of the Georgia Esoteric and Molecular Laboratory, Scientific Director of the Cytogenetics Laboratory of the Augusta University Medical Center and Adjunct Assistant professor of Pathology of the medical College of Georgia at Augusta University.